Moberg Pharma resolves on a directed issue of ordinary shares to guarantors in connection with the completed rights issue
STOCKHOLM, 8 June 2022. The Board of Directors of Moberg Pharma AB (publ) (OMX: MOB) (“Moberg Pharma” or the “Company”) has today resolved on a directed new issue of 536,952 ordinary shares to the guarantors in the rights issue of ordinary shares resolved upon by the Board of Directors on 8 April 2022 and approved by the Extraordinary General Meeting on 3 May 2022 (the “Rights Issue”) who have chosen to receive their guarantee commission in the form of newly issued ordinary shares in Moberg Pharma (the "Remuneration Issue"). The subscription price in the Remuneration Issue corresponds to the